Moneyta · stock research · no sign-up needed
NVO
FollowFigures below come straight from SEC filings: every number is the company's own, on the record.
Revenue (FY FY2025)
$309.1B
+119.5% y/y
Net income (FY FY2025)
$102.4B
as filed with the SEC
Institutions holding
1,367
+78 last quarter
Overview · Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. T…
Management team
- Jacob Martin Wiborg Rode · Head of Investor RelationsFind on LinkedIn
- Ms. Tania Sabroe · EVP of People, Organisation and Communication & Member of Management BoardFind on LinkedIn
- Mr. Ludovic Helfgott · Executive VP of Product & Portfolio Strategy and Member of Management BoardFind on LinkedIn
- Dr. Marcus Schindler Ph.D. · EVP of Research & Early Development, Chief Scientific Officer & Member of the Management BoardFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
What history says when its signals fire
Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence
The desk's Snapshot
members see every cardRead the full desk report on NVO
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
The full desk report
Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.
Who holds it, who's buying Gold
Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.
Largest holder
Net flow last quarter
Insider buys, 90d
Further reading
Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data: insight, not advice.